News & Updates

With a person dying every 30 seconds from a hepatitis related illness – we can’t wait to act on viral hepatitis.

Rh isoimmunization in Sub-Saharan Africa indicates need for universal access to anti-RhD immunoglobulin and effective management of D-negative pregnancies

AfricaBio is pleased to announce that registration is open for the 5th Annual BIO Africa Convention.
The convention taking place at the Durban ICC, under the theme “Africa Resilient: Life Sciences Innovation For Achieving Health and Food Security”.

ISTH 2022 is the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH), taking place in London, England, U.K., from July 9-13, 2022.

Hepatitis B and C place a significant public health burden on the Senegalese population.
Hepatitis B is highly endemic in Senegal. Comparatively, hepatitis C is less endemic but many individuals are still affected. In Senegal, recent studies have assessed the burden of viral hepatitis B and C with a prevalence rate of 8 to 9% for HBV and of 2% for HCV.
The fight against viral hepatitis in Senegal is being led by the National Program Against Hepatitis PNLH.

Did you know? The global pandemic led governments around the world to de-prioritise their hepatitis response as they attempted to…

Marchitalia is glad to announce the recent acquisition of a stake in Adec Pharma, a leading drug promotion agency in Ivory Coast. The agreement with Adec Pharma aims to strengthen the activities of Business Development and promotion of the Adec Pharma portfolio that includes serums for human use, vaccines, blood products and specialties.

Through Marchitalia 4you, Marchitalia reaffirms its commitment in the multicultural social partnering aimed to the resolution of the menstrual insecurity.

WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide.

After nearly five decades of effective prophylaxis in high-income countries, the incidence of rhesus haemolytic disease.